Ellen Schlette

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. ncbi CD79b expression in chronic lymphocytic leukemia. Association with trisomy 12 and atypical immunophenotype
    Ellen Schlette
    Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Arch Pathol Lab Med 127:561-6. 2003
  2. ncbi The t(14;19)(q32;q13)-positive small B-cell leukaemia: a clinicopathologic and cytogenetic study of seven cases
    Yang O Huh
    Department of Hematopathology, MD Anderson Cancer Centre, The University of Texas, Houston, TX 77030, USA
    Br J Haematol 136:220-8. 2007
  3. ncbi MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis
    Yang O Huh
    Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Br J Haematol 142:36-44. 2008
  4. ncbi The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas
    Claudiu V Cotta
    Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 112:552-61. 2008
  5. ncbi Immunophenotypic study of basophils by multiparameter flow cytometry
    Xiaohong Han
    Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, USA
    Arch Pathol Lab Med 132:813-9. 2008
  6. ncbi Expression of bcl-3 in chronic lymphocytic leukemia correlates with trisomy 12 and abnormalities of chromosome 19
    Ellen Schlette
    Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA
    Am J Clin Pathol 123:465-71. 2005
  7. ncbi Mature B-cell leukemias with more than 55% prolymphocytes: report of 2 cases with Burkitt lymphoma-type chromosomal translocations involving c-myc
    Shakil Merchant
    Division of Pathology and Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA
    Arch Pathol Lab Med 127:305-9. 2003
  8. ncbi Expression of Smac/DIABLO in B-cell non-Hodgkin and Hodgkin lymphomas
    Yongsheng Ren
    Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Hum Pathol 37:1407-13. 2006
  9. ncbi Indolent neuroendocrine tumor involving the bone marrow. A case report with a 9-year follow-up
    Ellen Schlette
    Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA
    Arch Pathol Lab Med 127:488-91. 2003
  10. ncbi Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens
    Katherine I Lin
    Leukemia Department, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Blood 113:3168-71. 2009

Collaborators

Detail Information

Publications12

  1. ncbi CD79b expression in chronic lymphocytic leukemia. Association with trisomy 12 and atypical immunophenotype
    Ellen Schlette
    Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Arch Pathol Lab Med 127:561-6. 2003
    ..CD79b is a relatively newly characterized B-cell marker that is expressed in a minority of chronic lymphocytic leukemia (CLL) cases...
  2. ncbi The t(14;19)(q32;q13)-positive small B-cell leukaemia: a clinicopathologic and cytogenetic study of seven cases
    Yang O Huh
    Department of Hematopathology, MD Anderson Cancer Centre, The University of Texas, Houston, TX 77030, USA
    Br J Haematol 136:220-8. 2007
    ..However, these neoplasms also differ from CLL cytologically and in their immunophenotype...
  3. ncbi MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis
    Yang O Huh
    Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Br J Haematol 142:36-44. 2008
    ..In summary, MYC rearrangement, which occurs rarely in CLL patients, is associated with increased prolymphocytes, complex cytogenetic abnormalities, and a poor prognosis...
  4. ncbi The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas
    Claudiu V Cotta
    Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 112:552-61. 2008
    ..Recent studies have shown that Id2 is overexpressed in some types of B-cell lymphoma, including classical Hodgkin lymphoma. The authors of the current study hypothesized that Id2 also is overexpressed in T-cell lymphomas...
  5. ncbi Immunophenotypic study of basophils by multiparameter flow cytometry
    Xiaohong Han
    Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, USA
    Arch Pathol Lab Med 132:813-9. 2008
    ..The immunophenotypic profile of basophils is not yet fully established, and the immunophenotypic changes in chronic myelogenous leukemia are not fully characterized...
  6. ncbi Expression of bcl-3 in chronic lymphocytic leukemia correlates with trisomy 12 and abnormalities of chromosome 19
    Ellen Schlette
    Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA
    Am J Clin Pathol 123:465-71. 2005
    ..Although the mechanism of bcl-3 expression is unclear, these results raise the possibility that bcl-3 may be involved in the pathogenesis of this subset of tumors and could be a potential target for investigational therapies...
  7. ncbi Mature B-cell leukemias with more than 55% prolymphocytes: report of 2 cases with Burkitt lymphoma-type chromosomal translocations involving c-myc
    Shakil Merchant
    Division of Pathology and Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA
    Arch Pathol Lab Med 127:305-9. 2003
    ..CONCLUSION: These results suggest that c-myc gene alterations may be involved in the pathogenesis of a subset of mature B-cell leukemias with more than 55% prolymphocytes...
  8. ncbi Expression of Smac/DIABLO in B-cell non-Hodgkin and Hodgkin lymphomas
    Yongsheng Ren
    Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Hum Pathol 37:1407-13. 2006
    ..These results may also have implications for using Smac/DIABLO or its agonists as therapeutic agents...
  9. ncbi Indolent neuroendocrine tumor involving the bone marrow. A case report with a 9-year follow-up
    Ellen Schlette
    Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA
    Arch Pathol Lab Med 127:488-91. 2003
    ..We suggest that this neuroendocrine tumor may have arisen in the bone marrow...
  10. ncbi Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens
    Katherine I Lin
    Leukemia Department, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Blood 113:3168-71. 2009
    ..8, P < .001). Our results suggest that postremission interventions should be targeted toward patients with unmutated IgV(H) status...
  11. ncbi Nelarabine activity in acute biphenotypic leukemia
    Yesid Alvarado
    Leuk Res 31:1600-3. 2007
  12. ncbi CD23 expression in mantle cell lymphoma: clinicopathologic features of 18 cases
    Ellen Schlette
    Dept of Hematopathology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 72, Houston, TX 77030, USA
    Am J Clin Pathol 120:760-6. 2003
    ..The frequency of CD23 expression by MCL is method-dependent, being typically dim and most commonly detected by flow cytometry. In this small study group, bone marrow and leukemic involvement were relatively common...